CLINICAL_TRIALS
trial_result
· 2024-02-09
Clinical Trial Update: Belimumab in Idiopathic Inflammatory Myositis [Phase 2, Phase 3]
Summary
A clinical trial update for belimumab in myositis (Phase 2 and Phase 3) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwell Health | Conditions: Myositis | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2024-02-09